Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Elyxyb (celecoxib)
i
Other names:
DFN15, DFN-15, DFN-15A, DFN-15B
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Collegium Pharma, Dr. Reddy’s, Sorrento
Drug class:
COX2 inhibitor
Related drugs:
‹
amlodipine/celecoxib (1)
parecoxib (1)
DRGT-46 (1)
CA102N (0)
apricoxib (0)
ECP-1014 (0)
celecoxib oral (0)
ETS2101 (0)
VT-11CR (0)
amlodipine/celecoxib (1)
parecoxib (1)
DRGT-46 (1)
CA102N (0)
apricoxib (0)
ECP-1014 (0)
celecoxib oral (0)
ETS2101 (0)
VT-11CR (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Basal Cell Carcinoma
No biomarker
Basal Cell Carcinoma
celecoxib
Resistant: A2 - Guideline
celecoxib
Resistant
:
A2
celecoxib
Resistant: A2 - Guideline
celecoxib
Resistant
:
A2
No biomarker
Squamous Cell Skin Cancer
No biomarker
Squamous Cell Skin Cancer
celecoxib
Resistant: A2 - Guideline
celecoxib
Resistant
:
A2
celecoxib
Resistant: A2 - Guideline
celecoxib
Resistant
:
A2
PIK3CA mutation
Head and Neck Cancer
PIK3CA mutation
Head and Neck Cancer
celecoxib
Sensitive: D – Preclinical
celecoxib
Sensitive
:
D
celecoxib
Sensitive: D – Preclinical
celecoxib
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login